Robert S. DiPaola, MD

The Best Hope for Finding a Cure: Precision Medicine Initiative Already Showing its Potential (NJBiz, March 23, 2015)

Dr. DiPaola Honored for Contributions to Oncology Field

Dr. DiPaola Authors Editorial in the Journal of Clincal Oncology

Journal of Clinical OncologyCabozantinib in Prostate Cancer:
The Beginning of
a Precision Paradigm?


View Dr. DiPaola's Research Profile

Dr. DiPaola Discusses Precision Medicine in UMDNJ Magazine, Winter 2013 Edition

Dr. DiPaola Receives Top Doc Honors in 2012 U.S. News & World Report


Dr. DiPaola Video
Video: Dr. DiPaola is interviewed by
NJ 101.5's David Matthau

Robert S. DiPaola, MD

Rutgers Cancer Institute of New Jersey

Vice Chancellor for Cancer Programs
Rutgers Biomedical and Health Sciences



As Cancer Center Director, Dr. DiPaola is responsible for research activities and administrative oversight of a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, and led the successful renewal of NCI designation in 2011. Dr. DiPaola has held multiple local and national positions including the founding Director and Program leader of the Prostate Cancer Center at the Cancer Institute of New Jersey (1996-2008); National Chairman of the Genitourinary Committee of the Eastern Oncology Cooperative Group (2004-2011); Chief of Medical Oncology at Robert Wood Johnson Medical School (2006-Current); and was appointed as Director of the Cancer Institute of New Jersey in 2008, after a national search. Dr. DiPaola has considerable experience in translational research focused on the study of prostate cancer and drug resistance locally and nationally. He was one of the earliest investigators to target the degradation of bcl-2 in both the laboratory and clinic as a means to restore drug sensitivity. His accomplishments in the area of translational research are underscored by grants from the NIH, Department of Defense, and private foundations, as well as his publications in prominent journals including the New England Journal of Medicine, JAMA, Cell, Clinical Cancer Research, and the Journal of Clinical Oncology.

Dr. DiPaola has maintained continuous federal peer-reviewed funding to support a laboratory focused on Drug Resistance in Cancer Therapy focused on preclinical studies that support translational clinical trials. He is PI of a Cancer Center Support Grant, a CINJ phase I/II U01 grant supporting translational clinical trials, and Department of Defense Prostate Consortium Grant focused on the development of translational studies in prostate cancer. As Chairman of the Genito-Urinary Committee of the Eastern Cooperative Oncology Group (ECOG) for a term from 2004 until 2011, he led the committee to develop National phase II and III studies, and through two successful NCI reviews. He continues as a full member of multiple NCI steering committees, including the investigational drug steering committee and the Genitourinary steering committee, and is chairman of an NCI apoptosis and autophagy task force. He was appointed as a full member of the National Cancer Institute's subcommittee A (parent committee) for Cancer Center reviews and was chairman for this year's American Society of Clinical Oncology's GU program committee.

Board Certifications

  • Diplomate, Internal Medicine,1991 - 2021
  • Diplomate, Medical Oncology,1995 - 2015
  • Hematology,1994 - 2004

Education / Training

  • Fellowship, Hematology-Oncology, University of Pennsylvania Hospital, Philadelphia, PA
  • Residency, Internal Medicine, Duke University Medical Center, Durham, NC
  • Internship, Internal Medicine, Duke University Medical Center, Durham, NC
  • MD, Medicine, University of Utah School of Medicine, Salt Lake City, UT
  • BS, Science, University of Utah, Salt Lake City, UT


Professional Organizations

  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • Eastern Cooperative Oncology Group (ECOG)
  • Oncology Society of New Jersey
  • Prostate Cancer Foundation (PCF)

Select Awards and Honors

  • Voted in “Best Doctors in America,” 1998, 2005, 2007, 2011, 2012, 2013
  • Awarded Research Mentor of the Year, Department of Medicine, UMDNJ-RWJMS, 2005
  • Awarded the ECOG 2003 Investigator Award, 2003
  • Voted in “CaRelations Physician of the Year,” 2000
  • Elected Junior Faculty Representative, RWJMS, 1996
  • American Cancer Society Clinical Oncology Fellowship Award, 1993 - 1994